Richter Gedeon Vegyeszeti Gyar Nyrt

Common Name
Gedeon Richter
Country
Hungary
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
12,167
Ticker
RICHTER
Exchange
BUDAPEST STOCK EXCHANGE
Description
Richter Gedeon Nyrt., founded in Hungary in 1901, is a leading pharmaceutical company with a broad spectrum in drug development, manufacture, market, and sales. Known for its strong innovation capabil...

Disclosures of Gedeon Richter

Explore Gedeon Richter's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Gedeon Richter's official channels and fully traceable to its official company sources.

The table below lists all of Gedeon Richter's' corporate disclosure by name and reporting period, ensuring full transparency and easy access. Coming soon, Tracenable users will be able to export disclosures as PDFs, view them in Markdown, or open them directly in ChatGPT or Claude for instant analysis and summarization.

NameReporting Period
Annual Report2024
Sustainability Report2023
Annual Report2023
Annual Report2022
Corporate Governance Report2022
Sustainability Report2022
Annual Report2021
Sustainability Report2021
Financial & Extra-Financial Disclosure2020
Annual Report2020
Sustainability Report2020
Annual Report2019
Sustainability Report2019
Financial Report2019
Annual Report2018
Financial Report2018
Sustainability Report2017
Annual Report2017
Financial Report2017
Financial Report2016
Sustainability Report2015
Financial Report2015
Sustainability Report2013
Sustainability Report2011
Sustainability Report2009
Sustainability Report2007
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?